Home » Authors » Don Long

Articles by Don Long

Tepha's combo DNA/polymer suture product 510(k)-cleared

Feb. 13, 2007

SomnoScreen reduces tethering for better sleep in a sleep lab

Feb. 12, 2007

Inverness reports over-allotment sale brings total to about $273M

Feb. 8, 2007

Financings roundup: Accuray IPO seeking $99.5M; Invacare prices $125M in notes

Feb. 7, 2007

CMS poised to reject VNS from Cyberonics to treat depression

Feb. 7, 2007

Multiple issues offering large openings for second-generation devices in this device/drug arena

Feb. 1, 2007

NuVasive acquires Formagraft via buy of Radius, Maxigen Bio

Jan. 26, 2007

‘Thermometer’ puts Bush health coverage plan in deep freeze

Jan. 25, 2007

Devices top Midwest financing of startups for a record year

Jan. 24, 2007

Auditor ‘going concern’ notice adds to Cyberonics’ headaches

Jan. 17, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...